Research Leaders / KOL Map

Idiopathic Pulmonary Fibrosis: Research Leaders and Landscape

The most active researchers, institutions, and subtopics in Idiopathic Pulmonary Fibrosis, from recent PubMed records. Public authorship only, every figure verifiable by PMID.

Analyzed 600 recent PubMed papers (2021-2026) matching "idiopathic pulmonary fibrosis antifibrotic treatment". Source: NLM PubMed. Generated July 2026.

Top research leaders (by recent publication volume)

#ResearcherAffiliationPapers
1Cottin VincentLouis Pradel Hospital15
2Kreuter MichaelMainz University Medical Center14
3Valenzuela ClaudiaHospital Universitario de la Princesa9
4Richeldi LucaFondazione Policlinico Universitario A. Gemelli IRCCS9
5Fujisawa TomoyukiHamamatsu University School of Medicine9
6Suda TakafumiHamamatsu University School of Medicine9
7Spagnolo PaoloUniversity of Padova8
8Huang HuiPeking Union Medical College Hospital8
9Suzuki YuzoHamamatsu University School of Medicine8
10Hozumi HironaoHamamatsu University School of Medicine8
11Song Jin WooUniversity of Ulsan College of Medicine7
12Crestani BrunoUniversité Paris Cité7
13Inoue YusukeHamamatsu University School of Medicine7
14Yasui HidekiHamamatsu University School of Medicine7
15Karayama MasatoHamamatsu University School of Medicine7
16Furuhashi KazukiHamamatsu University School of Medicine7
17Enomoto NoriyukiHamamatsu University School of Medicine7
18Inui NaokiHamamatsu University School of Medicine7

Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.

Leading institutions

College of Pharmacy (13), College of Medicine (12), University of Michigan (11), Hamamatsu University School of Medicine (11), Peking Union Medical College Hospital (10), Louis Pradel Hospital (9), University of Ulsan College of Medicine (9), Kanagawa Cardiovascular and Respiratory Center (8), University of California (8), University of Southern California (7)

Active subtopics

Idiopathic Pulmonary Fibrosis (293), Lung (158), Mice (141), Pulmonary Fibrosis (134), Bleomycin (129), Mice, Inbred C57BL (114), Antifibrotic Agents (105), Disease Models, Animal (97)

Top journals

Respiratory research (16), BMC pulmonary medicine (14), Scientific reports (13), International immunopharmacology (12), International journal of molecular sciences (12), Journal of clinical medicine (10)

Representative recent papers

Biological activity assessment of isolated flavonoid from Cordia sinensis: in vitro and in silico evaluation against idiopathic pu (2026) · PMID 42477189

Targeting alveolar type II cell dysfunction in idiopathic pulmonary fibrosis: Molecular mechanisms and emerging therapeutic strate (2026) · PMID 42464643

Progressive pulmonary fibrosis criteria predict mortality in treated idiopathic pulmonary fibrosis: a prospective cohort study. (2026) · PMID 42464208

Biomarker profiles in idiopathic and progressive pulmonary fibrosis after LPA (2026) · PMID 42458495

Natural therapeutics and traditional formulas targeting macrophage polarization in the fibrotic niche of idiopathic pulmonary fibr (2026) · PMID 42454057

Want the full cited brief?

A full Idiopathic Pulmonary Fibrosis brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.

Try the live tool Contact us